| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | K Y Yuen | |
| S S Y Wong | |||
| P433 | issue | 3 | |
| P921 | main subject | avian influenza | Q43987 |
| P304 | page(s) | 189-199 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Hong Kong Medical Journal | Q15760014 |
| P1476 | title | Human infection by avian influenza A H5N1 | |
| P478 | volume | 11 |
| Q30011014 | A statistical phylogeography of influenza A H5N1. |
| Q24187883 | Amantadine and rimantadine for influenza A in children and the elderly |
| Q30353527 | Avian influenza (H5N1): implications for intensive care. |
| Q45902241 | Avian influenza A/H5N1 neuraminidase expressed in yeast with a functional head domain. |
| Q30363356 | Avian influenza: the next pandemic? |
| Q92096633 | Breeding Influenza: The Political Virology of Offshore Farming |
| Q27487859 | Broad-Spectrum Drugs Against Viral Agents |
| Q57027404 | C-reactive protein as a biomarker of severe H1N1 influenza |
| Q99240709 | Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective |
| Q30374946 | Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus |
| Q25257105 | Expression of hemagglutinin protein from the avian influenza virus H5N1 in a baculovirus/insect cell system significantly enhanced by suspension culture |
| Q49838882 | IFN and cytokine responses in ducks to genetically similar H5N1 influenza A viruses of varying pathogenicity |
| Q35839143 | Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice |
| Q30010997 | Influenza A H5N1 immigration is filtered out at some international borders |
| Q64229581 | Innate Immune Responses to Avian Influenza Viruses in Ducks and Chickens |
| Q35804633 | Into the eye of the cytokine storm |
| Q30223960 | Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? |
| Q26825122 | Lipidomic profiling of bioactive lipids by mass spectrometry during microbial infections |
| Q42175114 | Matrix protein 1: A comparative in silico study on different strains of influenza A H5N1 Virus |
| Q37525450 | Nosocomial or hospital-acquired infections: an overview |
| Q98207417 | Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 |
| Q36171127 | Ode to oseltamivir and amantadine? |
| Q37241586 | Protein intrinsic disorder and influenza virulence: the 1918 H1N1 and H5N1 viruses |
| Q33575649 | Rapid semi-automated quantitative multiplex tandem PCR (MT-PCR) assays for the differential diagnosis of influenza-like illness |
| Q47551420 | Recent progress in the antiviral activity and mechanism study of pentacyclic triterpenoids and their derivatives. |
| Q37302701 | Subclinical infection with avian influenza A (H5N1) virus in cats. |
| Q38622954 | Systemic viral infections and collateral damage in the liver. |
| Q30399889 | The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D binding |
| Q36431924 | The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1--a review |
| Q95645944 | The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system |
| Q39407683 | The liver is a metabolic and immunologic organ: A reconsideration of metabolic decompensation due to infection in inborn errors of metabolism (IEM). |
| Q30396915 | The lower serum immunoglobulin G2 level in severe cases than in mild cases of pandemic H1N1 2009 influenza is associated with cytokine dysregulation |
| Q30366265 | The prospect of pandemic influenza: why should the optometrist be concerned about a public health problem? |
| Q36171279 | The use of antiviral drugs for influenza: recommended guidelines for practitioners |
| Q55379440 | Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections. |
| Q30353773 | Use of semiconductor-based oligonucleotide microarrays for influenza a virus subtype identification and sequencing. |
| Q91909541 | Viral lung infections and the potential for a human pandemic |
Search more.